会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 90. 发明授权
    • Meningococcal outer membrane vesicles
    • 脑膜炎球菌外膜囊泡
    • US08808711B2
    • 2014-08-19
    • US11661996
    • 2005-09-05
    • Philipp OsterMariagrazia PizzaRino Rappouli
    • Philipp OsterMariagrazia PizzaRino Rappouli
    • A61K39/095
    • A61K39/095A61K2039/545A61K2039/55555
    • OMVs targeted against specific epidemic strains can be highly effective in controlling localized outbreaks of disease. In combination with large-scale and reproducible manufacturing techniques, a vaccine can be rapidly produced after an outbreak. The invention provides a method for preparing a meningococcal outer membrane vesicle (OMV) vaccine, comprising the steps of: (i) identifying the serosubtype of a meningococcal strain associated with an outbreak of meningococcal meningitis; (ii) preparing OMVs from a meningococcal strain having the serosubtype identified in step (i) for use in vaccine manufacture. The method may comprise one or both of the further steps of (iii) formulating said OMVs as a vaccine; and (iv) distributing said vaccine in a geographical area affected by or likely to be affected by said outbreak. The meningococcal strain will typically be in serogroup B, but may be instead by in serogroup A, C, W135, Y, etc.
    • 针对特定流行株的OMV可以有效控制局部的疾病暴发。 结合大规模和可重现的制造技术,疫苗可以在爆发后迅速生产。 本发明提供了一种制备脑膜炎球菌外膜囊泡(OMV)疫苗的方法,包括以下步骤:(i)鉴定与脑膜炎球菌脑膜炎爆发相关的脑膜炎球菌菌株的血清型; (ii)从具有步骤(i)中鉴定的血清型的脑膜炎球菌菌株制备用于疫苗制造的OMV。 该方法可以包括以下一个或两个步骤:(iii)将所述OMV配制为疫苗; 和(iv)在受该疫情影响或受其影响的地理区域内分发疫苗。 脑膜炎球菌病毒株通常在血清组B中,但可以代之以血清群A,C,W135,Y等。